SHARE:  
Updates in Pediatrics
Editor: Jack Wolfsdorf, MD, FAAP
header with photos of various children
November 3, 2021 | Volume 12 | Issue 44
Lung function in children with Cystic Fibrosis (CF)

CF is a progressive autosomal recessive inherited disorder that causes severe damage primarily to the lungs and gastrointestinal systems (but also affects other organs). Children with CF have mutations in the cystic fibrosis trans-membrane conductant regulator (CFTR) gene which interferes with chloride and water movement to the surface of cells.


The CF gene abnormality results in less water in secreted mucus causing clogging of the lungs, pancreas, male reproductive system, etc. Clinical/severity of presentation varies however most children have recurrent pulmonary infection needing life-long therapy. Many live into their 30s or 40s; death occurring primarily due to respiratory failure.
 

Two Scandinavian studies in 5 specialized CF centers done 10 years apart on 629 and 738 CF patients respectively with pancreatic insufficiency only, which examined over time demographic data, lung function and infectious status indicates that mean age increases by 2.9 years (to 20.6 years), chronic P. aeruginosa infection falls from 44.7% to 36.3% and lung function remains unchanged (Mean FEV1 in children normal: >80%).


“Maintaining lung function in children with CF is possible with aggressive treatment”.
Laxative and cathartic use during breastfeeding

“Constipation is not uncommon in nursing mothers especially during the immediate post-partum period…”

A short article outlines the actions, benefits and side-effects of Docusate, Magnesium hydroxide (Milk of magnesia), Hydrocolloid (and others) in the lactating mother and breast feeding infant.

Hyperinflammation: On the pathogenesis and treatment of macrophage activation syndrome (MAS)
The immune system is the body’s defense system to fight virus-infected cells, malignant cells and to prevent exaggerated immune responses. One of the cells involved is the macrophage which not only destroys/ingests viruses/bacteria (hemophagocytosis) but also controls other cells in the immune system; T lymphocytes and cytokines also play a significant role. In children with macrophage activation syndrome (MAS), a subtype of Hemophagocytic lymphohistiocytosis (which may be Primary/genetic/familial or Secondary to a systemic disease like autoimmune disease, malignancy or infections like EB virus), the immune system response is uncontrolled leading to a hyper-inflammatory cytokine storm which can affect any organ system.

Clinically, “MAS is characterized by the rapid onset of overwhelming inflammation with unremitting fever, hepatosplenomegaly, liver dysfunction, lymphadenopathy, encephalopathy, purpura and bleeding” which can go on to life-threatening multiorgan failure. Early recognition is crucial and there no specific diagnostic test to differentiate MAS from any other systemic inflammatory disorder. Treatments are aimed at pacifying the inflammatory storm.
 
An interesting article outlines MAS pathogenesis, clinical and laboratory findings and therapeutic options (Well worth taking the time to read this complex article, ED).

REGISTER - LEARN - EARN CME CREDIT
"COVID-19 Vaccine & Treatment Updates – Dispelling the Myths"

This Virtual Grand Round was recorded LIVE and includes the post-session Q&A portion. This content is available for free - without CME credit (Fee may apply for those who wish to claim CME).
Monthly Features
Underwriting Opportunities
With a circulation of over 2000, Updates in Pediatrics offers an excellent opportunity to promote your brand at affordable rates. Contact Riccardo.Firmino@nicklaushealth.org


Advertising in this e-journal in no way implies endorsement of a product by Nicklaus Children's Hospital.